The global immunohistochemistry market size reached US$ 2.4 Billion in 2022. Looking forward, the market is expected to reach US$ 3.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.96% during 2022-2028.
Immunohistochemistry (IHC) is a laboratory method for checking specific antigens in a tissue sample using antibodies. The antibodies generally bind to an enzyme or a fluorescent dye, which helps researchers see an antigen under a microscope. IHC is widely used to diagnose chronic diseases like cancer and aids in distinguishing their types. As compared to conventional enzyme staining techniques that identify a limited number of proteins, enzymes, and tissue structures, IHC involves specific antigen-antibody reactions. As a result, it is gaining traction as a crucial technique in medical research laboratories and clinical diagnostics to visualize the distribution and localization of specific cellular components within cells.
Immunohistochemistry (IHC) is a laboratory method for checking specific antigens in a tissue sample using antibodies. The antibodies generally bind to an enzyme or a fluorescent dye, which helps researchers see an antigen under a microscope. IHC is widely used to diagnose chronic diseases like cancer and aids in distinguishing their types. As compared to conventional enzyme staining techniques that identify a limited number of proteins, enzymes, and tissue structures, IHC involves specific antigen-antibody reactions. As a result, it is gaining traction as a crucial technique in medical research laboratories and clinical diagnostics to visualize the distribution and localization of specific cellular components within cells.
Immunohistochemistry Market Trends
The sudden onset of coronavirus disease (COVID-19) has led to a global healthcare crisis. This is escalating the need for IHC for quick and effective drug development and diagnosis of the infection. Apart from this, significant growth in the number of individuals who have cancer, tumors, muscle diseases, and neurodegenerative disorders acts as another key factor driving the market. Moreover, IHC can characterize various biological processes and pathologies, including wound-healing, immune response, and tissue rejection and biomaterial interactions. As a result, it is gaining traction to determine the function of specific gene products in fundamental biological processes and confirm infectious agents in tissues. Moreover, several novel fluorescent dyes, excellent color contrast, high resolution, and simultaneous multicolor imaging have been introduced recently. These innovations are anticipated to make immunofluorescence microscopy a convenient tool for studying pathobiological processes at the cellular level in the forthcoming years.Key Market Segmentation
This research provides an analysis of the key trends in each sub-segment of the global immunohistochemistry market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on product, application, end use.Breakup by Product:
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Equipment
- Slide Staining Systems
- Tissue Microarrays
- Tissue Processing Systems
- Slide Scanners
- Reagents
- Histological Stains
- Blocking sera and Reagents
- Chromogenic Substrates
- Fixation Reagents
- Stabilizers
- Organic Solvents
- Proteolytic Enzymes
- Diluents
- Kits
Breakup by Application:
- Diagnostics
- Cancer
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
- Drug Testing
Breakup by End Use:
- Hospitals and Diagnostic Laboratories
- Research Institutes
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Latin America
- Brazil
- Mexico
- Middle East and Africa
Competitive Landscape
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, Bio SB Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Merck KGaA, Perkinelmer Inc. and Thermo Fisher Scientific Inc.Key Questions Answered in This Report:
- How has the global immunohistochemistry market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global immunohistochemistry market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global immunohistochemistry market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Immunohistochemistry Market
6 Market Breakup by Product
7 Market Breakup by Application
8 Market Breakup by End Use
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
Companies Mentioned
- Abcam plc
- Agilent Technologies Inc.
- Beckman Coulter Inc. (Danaher Corporation)
- Becton Dickinson and Company
- Bio SB Inc.
- Bio-Rad Laboratories Inc.
- Bio-Techne Corporation
- Cell Signaling Technology Inc.
- F. Hoffmann-La Roche AG
- Merck KGaA
- Perkinelmer Inc.
- Thermo Fisher Scientific Inc.
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 144 |
Published | November 2023 |
Forecast Period | 2022 - 2028 |
Estimated Market Value ( USD | $ 2.4 Billion |
Forecasted Market Value ( USD | $ 3.8 Billion |
Compound Annual Growth Rate | 8.0% |
Regions Covered | Global |
No. of Companies Mentioned | 12 |